NVCT
NVCT
US67080T1088
Nuvectis Pharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
689.44M EUR
490.92M EUR
205.04M EUR
193.86M EUR
Enterprise Value
633.71M EUR
468.76M EUR
179.91M EUR
162.23M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-22x
--
--
--
Price to Sales
--
--
--
--
Price to Book
62.12x
54.05x
14.42x
10.53x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.29%
-3.97%
-8.95%
-6.1%
ende